254 related items for PubMed ID: 15915010
1. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
Molimard M, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
[Abstract] [Full Text] [Related]
2. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[Abstract] [Full Text] [Related]
3. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[Abstract] [Full Text] [Related]
4. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[Abstract] [Full Text] [Related]
5. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
Langley SJ, Houghton CM, Singh SD.
Respiration; 2005; 72 Suppl 1():35-7. PubMed ID: 15915011
[Abstract] [Full Text] [Related]
6. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[Abstract] [Full Text] [Related]
7. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ, Senn S, Mezzanotte WS.
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[Abstract] [Full Text] [Related]
8. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM, Langley SJ, Singh SD, Holden J, Monici Preti AP, Acerbi D, Poli G, Woodcock A.
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[Abstract] [Full Text] [Related]
9. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
Drugs; 2006 Oct; 66(17):2235-54. PubMed ID: 17137405
[Abstract] [Full Text] [Related]
10. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[Abstract] [Full Text] [Related]
11. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[Abstract] [Full Text] [Related]
12. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[Abstract] [Full Text] [Related]
13. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE.
Drugs; 2009 Jan; 69(5):549-65. PubMed ID: 19368417
[Abstract] [Full Text] [Related]
14. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
Drugs; 2008 Jan; 68(14):1975-2000. PubMed ID: 18778120
[Abstract] [Full Text] [Related]
15. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[Abstract] [Full Text] [Related]
16. Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD.
Brusasco V, Canonica GW, Dal Negro R, Scano G, Paggiaro P, Fabbri LM, Barisione G, D'Amato G, Varoli G, Baroffio M, Milanese M, Mereu C, Crimi E.
J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):235-43. PubMed ID: 21689019
[Abstract] [Full Text] [Related]
17. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
Dahl R, Creemers JP, Van Noord J, Sips A, Della Cioppa G, Thomson M, Andriano K, Kottakis J, Fashola T.
Respiration; 2004 Oct; 71(2):126-33. PubMed ID: 15031566
[Abstract] [Full Text] [Related]
18. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
Dubakiene R, Nargela R, Sakalauskas R, Vahteristo M, Silvasti M, Lähelmä S.
Respiration; 2006 Oct; 73(4):441-8. PubMed ID: 16432294
[Abstract] [Full Text] [Related]
19. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G.
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[Abstract] [Full Text] [Related]
20. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Singh D, Piccinno A, Borrill Z, Poli G, Acerbi D, Meuleners L, Woodcock A.
Pulm Pharmacol Ther; 2008 Jul; 21(3):551-7. PubMed ID: 18321744
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
